Home
About
Us
Clinical Trial
Products
Clinical Data
Clinicians
News
Contact
Us
Home
About
Us
Clinical Trial
Products
Clinical Data
Clinicians
News
Contact
Us
Clinical Data
Studies continue to support the RenovoCath for targeted treatment of pancreatic cancer. Following are highlights from journals and industry presentations.
Trans Arterial Chemotherapy for Treatment of Locally Advanced Pancreatic Cancer: Treatment Factors Impacting Survival.
Presented at SIR 2020 Virtual
, June 13-14, 2020
Targeted Intra-Arterial Gemcitabine: Impact on Survival in Patients with Locally Advanced Pancreatic Cancer –A New Treatment Paradigm.
Presented at the World Congress on Pancreatic Cancer & Liver Diseases
, October 23, 2019
Management of Advanced Stage Hepatocellular Carcinoma with Extensive Portal Vein Tumor Thrombus Using an Adjustable Dual Balloon Occlusion Technique.
Published in Journal of Vascular and Interventional Radiology
, July, 2019
Localized Intra-arterial Gemcitabine: Impact on Survival in Patients with LAPC – a New Treatment Paradigm.
Presented at Pancreas Club Annual Meeting
, May 18, 2019
New Experience with Transarterial Micro-Perfusion (TAMP).
Presented at GEST 2019
, May 11, 2019
Treatment of Hepatic Tumors with Inaccessible Vasculature Using an Adjustable Length Dual Occlusion Balloon Catheter System.
Journal of Vascular & Interventional Radiology
, September 2018
Safety Study of Targeted and Localized Intra-Arterial Delivery of Gemcitabine in Patients with Locally Advanced Pancreatic Adenocarcinoma.
Journal of Pancreatic Cancer
, August 2017
Intra-arterial Targeted Delivery of Gemcitabine in Treatment of Patients with Loco-regional Pancreatic Tumors.
Presented at AHPBA Annual Meeting
, April 2, 2017
Treatment of Hepatic Tumors with Inaccessible Vasculature Using an Adjustable Length Dual Occlusion
Pancreatic Cancer: Chemoembolization Using A Double Balloon Catheter.
Presented at AIM Symposium
, November 14, 2016
Intra-arterial Targeted Delivery of Gemcitabine in Treatment of Patients with Loco-regional Pancreatic Tumors.
Poster presented to 50th Annual Pancreas Club Meeting
, May 20-21, 2016
Pancreas Club Abstract
: Is Intra-Arterial with Targeted Delivery of Gemcitabine Safe in Treatment of Patients with Loco-Regional Pancreatic Tumors?
May 20-21, 2016
IHPBA 2016 Abstract
: Intra-arterial and Tumor-Targeted Infusion of Gemcitabine in Patients with Unresectable Pancreatic Cancer,
April 20-23, 2016
Menu
